Scienture Inc. (SCNX)
NASDAQ: SCNX
· Real-Time Price · USD
1.01
-0.04 (-3.81%)
At close: Jun 17, 2025, 1:19 PM
Company Description
TRxADE HEALTH, Inc. operates as health services IT company.
It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies.
TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Scienture Inc.
| Country | United States |
| IPO Date | Feb 6, 2014 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Dr. Shankar Hariharan Ph.D. |
Contact Details
Address: 6308 Benjamin Rd Tampa, Florida United States | |
| Website | https://www.trxadehealth.com |
Stock Details
| Ticker Symbol | SCNX |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001382574 |
| CUSIP Number | n/a |
| ISIN Number | US80880X1046 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shankar Hariharan Ph.D. | Founder, Chief Executive Officer & Director |
| Eric Sherb CPA | Chief Financial Officer |
| Rahul Surana M.B.A., Ph.D. | Executive Vice President & Chief Operating Officer of Scienture LLC |
| Michele Rath | Senior Vice President & Chief Commercial Officer of Scienture LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 16, 2025 | POS AM | Filing |
| May 22, 2025 | 8-K | Current Report |
| May 12, 2025 | 10-Q | Quarterly Report |
| Apr 24, 2025 | 424B3 | Filing |
| Apr 11, 2025 | EFFECT | Filing |
| Apr 11, 2025 | 424B3 | Filing |
| Apr 11, 2025 | 8-K | Current Report |
| Apr 04, 2025 | S-1 | Filing |
| Mar 26, 2025 | 10-K | Annual Report |
| Mar 21, 2025 | 8-K | Current Report |